active nbsp inflammasom subset mater ilÎ² italic act lung injury ali result inflamed fibrosis investing role vimentin type iii intermedia filament process use three wellcharacter marin model known require demons central pathophysiolog event level endothelial alveolar epithet barrier permeable remodel attend lung him mouse challenge lp bleomycin asbestos bone marrow chime lack reduce follow exposure furthermore decrease active caps observe vitro vimentinknockdown macrophages importantly show direct proteinprotein interact studi provide insight suggest may key regal supplementary inform online version article doincomm contain mater avail author user 